8266 Federal Register / Vol. 87, No. 30 / Monday, February 14, 2022 / Notices 

The agenda for the March 15–16, 

2022, meeting is being finalized and 

may include the following topics: 

Federal program updates; COVID–19 

updates; race-concordant care, health of 

indigenous mothers and babies; and, the 

impact of violence on infant and 

maternal mortality. Agenda items are 

subject to change as priorities dictate. 

Refer to the ACIMM website listed 

above for any updated information 

concerning the meeting. 

Members of the public will have the 

opportunity to provide written or oral 

comments. Requests to submit a written 

statement or make oral comments to 

ACIMM should be sent to Anne Leitch 

using the email address above at least 3 

business days prior to the meeting. 

Public participants may submit written 

statements in advance of the scheduled 

meeting by emailing SACIM@hrsa.gov. 

Oral comments will be honored in the 

order they are requested and may be 

limited as time allows. 

Individuals who plan to attend and 

need special assistance or some 

reasonable accommodation should 

notify Anne Leitch at the contact 

information listed above at least 10 

business days prior to the meeting. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2022–03027 Filed 2–11–22; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Health Security Strategy 

AGENCY: Office of the Assistant 

Secretary for Preparedness and 

Response (ASPR), Department of Health 

and Human Services (HHS). 

ACTION: Request for information. 

SUMMARY: The Office of the Assistant 

Secretary for Preparedness and 

Response (ASPR), within the U.S. 

Department of Health and Human 

Services (HHS), is soliciting public 

comment regarding national health 

security threats, challenges, and 

promising practices to help inform the 

development of the 2023–2026 National 

Health Security Strategy (NHSS). Since 

2006, Congress has required the 

Secretary of HHS to develop and submit 

a 4-year NHSS and implementation plan 

that describe ‘‘potential emergency 

health security threats and identify the 

process to be prepared to identify and 

respond to such threats.’’ The 

quadrennial NHSS is a key U.S. 

Government vehicle for advancing 

public health and medical emergency 

capabilities, and serves as a tool to 

address priority threats, measure 

progress, identify gaps, and focus action 

to implement national health security 

capabilities. 

DATES: Comments must be received by 

March 11, 2022. 

ADDRESSES: Comments must be 

submitted electronically via email to the 

following email address: NHSS@

hhs.gov. 

Instructions: Emails to NHSS@hhs.gov 

in response to this announcement 

should include ‘2023–2026 NHSS 

comments’ in the subject line. 

Responses to the Request for 

Information may be placed in the body 

of the email or in an attachment to the 

email using a standard document 

format. 

Request for Information: HHS/ASPR 

is preparing to draft the 2023–2026 

NHSS. To help inform this strategy, 

HHS/ASPR is soliciting public comment 

regarding health security threats, 

challenges, and promising practices that 

may warrant being addressed in the 

2023–2026 NHSS. We invite your 

response to the following questions. 

Please note that you are not limited to 

the questions below and we welcome 

additional feedback. 

• What are the most critical national 

health security threats and public health 

and medical preparedness, response, 

and recovery challenges that warrant 

increased attention over the next five 

years? 

• What medium-term and long-term 

(i.e., over next five years) actions should 

be taken to mitigate these challenges at 

the federal government and/or state, 

local, tribal, and territorial level? 

• What public health and medical 

preparedness, response, and recovery 

opportunities or promising practices 

should be capitalized on over the next 

five years? 

Disclaimer and Important Notes: This 

notice is intended for planning purposes 

and does not constitute a formal 

agreement that information from public 

responses will be included in the 2023– 

2026 NHSS. 

FOR FURTHER INFORMATION CONTACT: 

Darrin Donato, Chief, Domestic Policy 

Branch, Division of Policy, Office of 

Strategy, Policy, Planning, and 

Requirements, ASPR, HHS, Washington, 

DC, NHSS@hhs.gov. 

Dawn O’Connell, 

Assistant Secretary for Preparedness and 

Response. 

[FR Doc. 2022–03046 Filed 2–11–22; 8:45 am] 

BILLING CODE 4150–37–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review Amended; 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Biomedical Sensing, 

Measurement and Instrumentation 

Study Section, March 10–11, 2022, 9:30 

a.m. to 7:00 p.m., which was published 

in the Federal Register on February 08, 

2022, 87 FR 7194, FR DOC #2022– 

02598. 

This meeting is being amended to 

change the Contact Person from Yuanna 

Cheng to James J. Li, Ph.D., Scientific 

Review Officer, Center for Scientific 

Review, National Institutes of Health, 

6701 Rockledge Drive, Room 5148, MSC 

7849, Bethesda, MD. The meeting dates, 

times, and meeting location remain the 

same. The meeting is closed to the 

public. 

Dated: February 8, 2022. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–03054 Filed 2–11–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Cancer Institute 

Council of Research Advocates. 

The meeting will be held as a virtual 

meeting and is open to the public. 

Individuals who plan to view the virtual 

meeting and need special assistance or 

other reasonable accommodations to 

view the meeting, should notify the 

Contact Person listed below in advance 

of the meeting. The meeting will be 

videocast and can be accessed from the 

NIH Videocasting and Podcasting 

website (http://videocast.nih.gov). 

Name of Committee: National Cancer 

Institute Council of Research Advocates. 

Date: March 9, 2022. 

Time: 12:00 p.m. to 4:15 p.m. 

Agenda: Welcome and Chairman’s 

Remarks, NCI Updates, Legislative Update, 

and Director’s Update. 

Place: National Institutes of Health, 9000 

Rockville Pike, Bethesda, MD 20892 (Virtual 

Meeting). 


jspears on DSK121TN23PROD with NOTICES1